Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 162

1.

Reply to Koehler, et al.

Beganovic M, Luther MK, Rice LB, Arias CA, Rybak MJ, LaPlante KL.

Clin Infect Dis. 2019 Feb 1. doi: 10.1093/cid/ciz057. [Epub ahead of print] No abstract available.

PMID:
30715221
2.

The Enterococcus: a Model of Adaptability to Its Environment.

García-Solache M, Rice LB.

Clin Microbiol Rev. 2019 Jan 30;32(2). pii: e00058-18. doi: 10.1128/CMR.00058-18. Print 2019 Mar 20. Review.

PMID:
30700430
3.

The structures of penicillin-binding protein 4 (PBP4) and PBP5 from Enterococci provide structural insights into β-lactam resistance.

Moon TM, D'Andréa ÉD, Lee CW, Soares A, Jakoncic J, Desbonnet C, Garcia-Solache M, Rice LB, Page R, Peti W.

J Biol Chem. 2018 Nov 30;293(48):18574-18584. doi: 10.1074/jbc.RA118.006052. Epub 2018 Oct 24.

PMID:
30355734
4.

Antimicrobial Stewardship and Antimicrobial Resistance.

Rice LB.

Med Clin North Am. 2018 Sep;102(5):805-818. doi: 10.1016/j.mcna.2018.04.004. Epub 2018 Jul 14. Review.

PMID:
30126572
5.

Structural and Regulatory Changes in PBP4 Trigger Decreased β-Lactam Susceptibility in Enterococcus faecalis.

Rice LB, Desbonnet C, Tait-Kamradt A, Garcia-Solache M, Lonks J, Moon TM, D'Andréa ÉD, Page R, Peti W.

MBio. 2018 Apr 3;9(2). pii: e00361-18. doi: 10.1128/mBio.00361-18.

6.

A Review of Combination Antimicrobial Therapy for Enterococcus faecalis Bloodstream Infections and Infective Endocarditis.

Beganovic M, Luther MK, Rice LB, Arias CA, Rybak MJ, LaPlante KL.

Clin Infect Dis. 2018 Jul 2;67(2):303-309. doi: 10.1093/cid/ciy064.

PMID:
29390132
7.

High-Level Fosfomycin Resistance in Vancomycin-Resistant Enterococcus faecium.

Guo Y, Tomich AD, McElheny CL, Cooper VS, Tait-Kamradt A, Wang M, Hu F, Rice LB, Sluis-Cremer N, Doi Y.

Emerg Infect Dis. 2017 Nov;23(11):1902-1904. doi: 10.3201/eid2311.171130.

8.

Factors essential for L,D-transpeptidase-mediated peptidoglycan cross-linking and β-lactam resistance in Escherichia coli.

Hugonnet JE, Mengin-Lecreulx D, Monton A, den Blaauwen T, Carbonnelle E, Veckerlé C, Brun YV, van Nieuwenhze M, Bouchier C, Tu K, Rice LB, Arthur M.

Elife. 2016 Oct 21;5. pii: e19469. doi: 10.7554/eLife.19469.

9.

Homologous Recombination within Large Chromosomal Regions Facilitates Acquisition of β-Lactam and Vancomycin Resistance in Enterococcus faecium.

García-Solache M, Lebreton F, McLaughlin RE, Whiteaker JD, Gilmore MS, Rice LB.

Antimicrob Agents Chemother. 2016 Sep 23;60(10):5777-86. doi: 10.1128/AAC.00488-16. Print 2016 Oct.

10.

Vancomycin-Resistant Enterococci: Therapeutic Challenges in the 21st Century.

Miller WR, Murray BE, Rice LB, Arias CA.

Infect Dis Clin North Am. 2016 Jun;30(2):415-439. doi: 10.1016/j.idc.2016.02.006. Review.

PMID:
27208766
11.

Draft Genome Sequence of Vancomycin-Susceptible, Ampicillin-Intermediate Enterococcus faecium Strain D344RRF.

García-Solache M, Rice LB.

Genome Announc. 2016 May 5;4(3). pii: e01720-15. doi: 10.1128/genomeA.01720-15.

12.

Genome Sequence of the Multiantibiotic-Resistant Enterococcus faecium Strain C68 and Insights on the pLRM23 Colonization Plasmid.

García-Solache M, Rice LB.

Genome Announc. 2016 May 5;4(3). pii: e01719-15. doi: 10.1128/genomeA.01719-15.

14.

Ampicillin in Combination with Ceftaroline, Cefepime, or Ceftriaxone Demonstrates Equivalent Activities in a High-Inoculum Enterococcus faecalis Infection Model.

Luther MK, Rice LB, LaPlante KL.

Antimicrob Agents Chemother. 2016 Apr 22;60(5):3178-82. doi: 10.1128/AAC.03126-15. Print 2016 May.

15.

Inhibition of bacterial and fungal pathogens by the orphaned drug auranofin.

Fuchs BB, RajaMuthiah R, Souza AC, Eatemadpour S, Rossoni RD, Santos DA, Junqueira JC, Rice LB, Mylonakis E.

Future Med Chem. 2016;8(2):117-32. doi: 10.4155/fmc.15.182. Epub 2016 Jan 25.

16.

Differential Effects of Penicillin Binding Protein Deletion on the Susceptibility of Enterococcus faecium to Cationic Peptide Antibiotics.

Sakoulas G, Kumaraswamy M, Nonejuie P, Werth BJ, Rybak MJ, Pogliano J, Rice LB, Nizet V.

Antimicrob Agents Chemother. 2015 Oct;59(10):6132-9. doi: 10.1128/AAC.00486-15. Epub 2015 Jul 20.

17.

A New AAC Section: Translating Resistance to the Bedside.

Arias CA, Rice LB.

Antimicrob Agents Chemother. 2015 Aug;59(8):4365. doi: 10.1128/AAC.01138-15. No abstract available.

18.

Mutation landscape of acquired cross-resistance to glycopeptide and β-lactam antibiotics in Enterococcus faecium.

Sacco E, Cortes M, Josseaume N, Bouchier C, Dubée V, Hugonnet JE, Mainardi JL, Rice LB, Arthur M.

Antimicrob Agents Chemother. 2015 Sep;59(9):5306-15. doi: 10.1128/AAC.00634-15. Epub 2015 Jun 15.

19.

Will use of combination cephalosporin/azithromycin therapy forestall resistance to cephalosporins in Neisseria gonorrhoeae?

Rice LB.

Sex Transm Infect. 2015 Jun;91(4):238-40. doi: 10.1136/sextrans-2014-051730. Epub 2015 Apr 29. No abstract available.

PMID:
25926405
20.

Vancomycin-resistant enterococci colonization among dialysis patients: a meta-analysis of prevalence, risk factors, and significance.

Zacharioudakis IM, Zervou FN, Ziakas PD, Rice LB, Mylonakis E.

Am J Kidney Dis. 2015 Jan;65(1):88-97. doi: 10.1053/j.ajkd.2014.05.016. Epub 2014 Jul 17.

PMID:
25042816
21.

MRSA and VRE colonization in solid organ transplantation: a meta-analysis of published studies.

Ziakas PD, Pliakos EE, Zervou FN, Knoll BM, Rice LB, Mylonakis E.

Am J Transplant. 2014 Aug;14(8):1887-94.

22.

Serine/threonine protein phosphatase-mediated control of the peptidoglycan cross-linking L,D-transpeptidase pathway in Enterococcus faecium.

Sacco E, Cortes M, Josseaume N, Rice LB, Mainardi JL, Arthur M.

MBio. 2014 Jul 8;5(4):e01446-14. doi: 10.1128/mBio.01446-14.

23.

In memoriam: Robert C. Moellering, Jr.

Rice LB, Eliopoulos GM, Jacoby GA.

Antimicrob Agents Chemother. 2014 Jul;58(7):3583-4. doi: 10.1128/AAC.03199-14. Epub 2014 May 5. No abstract available.

24.

Enterococcal Infection—Treatment and Antibiotic Resistance.

Kristich CJ, Rice LB, Arias CA.

In: Gilmore MS, Clewell DB, Ike Y, Shankar N, editors. Enterococci: From Commensals to Leading Causes of Drug Resistant Infection [Internet]. Boston: Massachusetts Eye and Ear Infirmary; 2014-.
2014 Feb 6.

25.

Peptidoglycan cross-linking in glycopeptide-resistant Actinomycetales.

Hugonnet JE, Haddache N, Veckerlé C, Dubost L, Marie A, Shikura N, Mainardi JL, Rice LB, Arthur M.

Antimicrob Agents Chemother. 2014;58(3):1749-56. doi: 10.1128/AAC.02329-13. Epub 2014 Jan 6.

26.

In memoriam: John P. Quinn, MD.

Perez F, Arias CA, Bush K, Drusano GL, Lolans K, Munoz-Price LS, Nicolau DP, Queenan AM, Rice LB, Segreti J, Shlaes DM, Weinstein RA, Bonomo RA.

Clin Infect Dis. 2014 Mar;58(5):748-50. doi: 10.1093/cid/cit801. Epub 2013 Dec 12. No abstract available.

27.

Trends and significance of VRE colonization in the ICU: a meta-analysis of published studies.

Ziakas PD, Thapa R, Rice LB, Mylonakis E.

PLoS One. 2013 Sep 27;8(9):e75658. doi: 10.1371/journal.pone.0075658. eCollection 2013.

28.
29.

Kinetic features of L,D-transpeptidase inactivation critical for β-lactam antibacterial activity.

Triboulet S, Dubée V, Lecoq L, Bougault C, Mainardi JL, Rice LB, Ethève-Quelquejeu M, Gutmann L, Marie A, Dubost L, Hugonnet JE, Simorre JP, Arthur M.

PLoS One. 2013 Jul 4;8(7):e67831. doi: 10.1371/journal.pone.0067831. Print 2013.

30.

A novel genetic region flanks the plasmid-carried blaNDM-1 isolated from a patient in Rhode Island in 2012.

Rice LB, Tait-Kamradt A.

Antimicrob Agents Chemother. 2013 Aug;57(8):4084-5. doi: 10.1128/AAC.00937-13. Epub 2013 Jun 3. No abstract available.

31.

Photodynamic and antibiotic therapy impair the pathogenesis of Enterococcus faecium in a whole animal insect model.

Chibebe Junior J, Fuchs BB, Sabino CP, Junqueira JC, Jorge AO, Ribeiro MS, Gilmore MS, Rice LB, Tegos GP, Hamblin MR, Mylonakis E.

PLoS One. 2013;8(2):e55926. doi: 10.1371/journal.pone.0055926. Epub 2013 Feb 14.

32.

Intrinsic and acquired resistance mechanisms in enterococcus.

Hollenbeck BL, Rice LB.

Virulence. 2012 Aug 15;3(5):421-33. doi: 10.4161/viru.21282. Epub 2012 Aug 15. Review.

33.

Gastrointestinal bacteria will have its way.

Rice LB.

J Infect Dis. 2012 Nov;206(9):1334-5. doi: 10.1093/infdis/jis512. Epub 2012 Aug 28. No abstract available.

PMID:
22930810
34.

Early insights into the interactions of different β-lactam antibiotics and β-lactamase inhibitors against soluble forms of Acinetobacter baumannii PBP1a and Acinetobacter sp. PBP3.

Papp-Wallace KM, Senkfor B, Gatta J, Chai W, Taracila MA, Shanmugasundaram V, Han S, Zaniewski RP, Lacey BM, Tomaras AP, Skalweit MJ, Harris ME, Rice LB, Buynak JD, Bonomo RA.

Antimicrob Agents Chemother. 2012 Nov;56(11):5687-92. doi: 10.1128/AAC.01027-12. Epub 2012 Aug 20.

35.

Kinetic analysis of Enterococcus faecium L,D-transpeptidase inactivation by carbapenems.

Dubée V, Arthur M, Fief H, Triboulet S, Mainardi JL, Gutmann L, Sollogoub M, Rice LB, Ethève-Quelquejeu M, Hugonnet JE.

Antimicrob Agents Chemother. 2012 Jun;56(6):3409-12. doi: 10.1128/AAC.06398-11. Epub 2012 Mar 26.

36.

Mechanisms of resistance and clinical relevance of resistance to β-lactams, glycopeptides, and fluoroquinolones.

Rice LB.

Mayo Clin Proc. 2012 Feb;87(2):198-208. doi: 10.1016/j.mayocp.2011.12.003. Review.

37.

Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance.

Magiorakos AP, Srinivasan A, Carey RB, Carmeli Y, Falagas ME, Giske CG, Harbarth S, Hindler JF, Kahlmeter G, Olsson-Liljequist B, Paterson DL, Rice LB, Stelling J, Struelens MJ, Vatopoulos A, Weber JT, Monnet DL.

Clin Microbiol Infect. 2012 Mar;18(3):268-81. doi: 10.1111/j.1469-0691.2011.03570.x. Epub 2011 Jul 27.

38.

Analysis of PBP5 of early U.S. isolates of Enterococcus faecium: sequence variation alone does not explain increasing ampicillin resistance over time.

Galloway-Peña JR, Rice LB, Murray BE.

Antimicrob Agents Chemother. 2011 Jul;55(7):3272-7. doi: 10.1128/AAC.00099-11. Epub 2011 May 16.

39.

Inactivation kinetics of a new target of beta-lactam antibiotics.

Triboulet S, Arthur M, Mainardi JL, Veckerlé C, Dubée V, Nguekam-Moumi A, Gutmann L, Rice LB, Hugonnet JE.

J Biol Chem. 2011 Jul 1;286(26):22777-84. doi: 10.1074/jbc.M111.239988. Epub 2011 May 4.

40.

Rapid diagnostics and appropriate antibiotic use.

Rice LB.

Clin Infect Dis. 2011 May;52 Suppl 4:S357-60. doi: 10.1093/cid/cir051. Review.

PMID:
21460296
41.

The hylEfm gene in pHylEfm of Enterococcus faecium is not required in pathogenesis of murine peritonitis.

Panesso D, Montealegre MC, Rincón S, Mojica MF, Rice LB, Singh KV, Murray BE, Arias CA.

BMC Microbiol. 2011 Jan 25;11(1):20. doi: 10.1186/1471-2180-11-20.

42.

Emergence of linezolid-resistant Staphylococcus aureus after prolonged treatment of cystic fibrosis patients in Cleveland, Ohio.

Endimiani A, Blackford M, Dasenbrook EC, Reed MD, Bajaksouszian S, Hujer AM, Rudin SD, Hujer KM, Perreten V, Rice LB, Jacobs MR, Konstan MW, Bonomo RA.

Antimicrob Agents Chemother. 2011 Apr;55(4):1684-92. doi: 10.1128/AAC.01308-10. Epub 2011 Jan 24.

43.

Progress and challenges in implementing the research on ESKAPE pathogens.

Rice LB.

Infect Control Hosp Epidemiol. 2010 Nov;31 Suppl 1:S7-10. doi: 10.1086/655995.

PMID:
20929376
44.

Multiple copies of functional, Tet(M)-encoding Tn916-like elements in a clinical Enterococcus faecium isolate.

Rice LB, Carias LL, Rudin S, Hutton RA, Marshall S.

Plasmid. 2010 Nov;64(3):150-5. doi: 10.1016/j.plasmid.2010.06.003. Epub 2010 Jun 25.

45.

Evaluation of a commercial microarray system for detection of SHV-, TEM-, CTX-M-, and KPC-type beta-lactamase genes in Gram-negative isolates.

Endimiani A, Hujer AM, Hujer KM, Gatta JA, Schriver AC, Jacobs MR, Rice LB, Bonomo RA.

J Clin Microbiol. 2010 Jul;48(7):2618-22. doi: 10.1128/JCM.00568-10. Epub 2010 May 26.

46.

Activation of the L,D-transpeptidation peptidoglycan cross-linking pathway by a metallo-D,D-carboxypeptidase in Enterococcus faecium.

Sacco E, Hugonnet JE, Josseaume N, Cremniter J, Dubost L, Marie A, Patin D, Blanot D, Rice LB, Mainardi JL, Arthur M.

Mol Microbiol. 2010 Feb;75(4):874-85. doi: 10.1111/j.1365-2958.2009.07014.x. Epub 2009 Dec 16.

47.

In vitro activity of fosfomycin against blaKPC-containing Klebsiella pneumoniae isolates, including those nonsusceptible to tigecycline and/or colistin.

Endimiani A, Patel G, Hujer KM, Swaminathan M, Perez F, Rice LB, Jacobs MR, Bonomo RA.

Antimicrob Agents Chemother. 2010 Jan;54(1):526-9. doi: 10.1128/AAC.01235-09. Epub 2009 Nov 9.

48.

The clinical consequences of antimicrobial resistance.

Rice LB.

Curr Opin Microbiol. 2009 Oct;12(5):476-81. doi: 10.1016/j.mib.2009.08.001. Epub 2009 Aug 27. Review.

PMID:
19716760
49.

Cotransfer of antibiotic resistance genes and a hylEfm-containing virulence plasmid in Enterococcus faecium.

Arias CA, Panesso D, Singh KV, Rice LB, Murray BE.

Antimicrob Agents Chemother. 2009 Oct;53(10):4240-6. doi: 10.1128/AAC.00242-09. Epub 2009 Aug 10.

50.

Role of class A penicillin-binding proteins in the expression of beta-lactam resistance in Enterococcus faecium.

Rice LB, Carias LL, Rudin S, Hutton R, Marshall S, Hassan M, Josseaume N, Dubost L, Marie A, Arthur M.

J Bacteriol. 2009 Jun;191(11):3649-56. doi: 10.1128/JB.01834-08. Epub 2009 Mar 20.

Supplemental Content

Support Center